These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


811 related items for PubMed ID: 25186731

  • 1. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.
    Huang J, Kang BH, Pancera M, Lee JH, Tong T, Feng Y, Imamichi H, Georgiev IS, Chuang GY, Druz A, Doria-Rose NA, Laub L, Sliepen K, van Gils MJ, de la Peña AT, Derking R, Klasse PJ, Migueles SA, Bailer RT, Alam M, Pugach P, Haynes BF, Wyatt RT, Sanders RW, Binley JM, Ward AB, Mascola JR, Kwong PD, Connors M.
    Nature; 2014 Nov 06; 515(7525):138-42. PubMed ID: 25186731
    [Abstract] [Full Text] [Related]

  • 2. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y, Man L, Qiu Z, Yang L, Sun Y, He Y.
    Antiviral Res; 2016 Aug 06; 132():252-61. PubMed ID: 27387828
    [Abstract] [Full Text] [Related]

  • 3. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, Mascola JR, Robinson JE, Ward AB, Williamson C, Kwong PD, Morris L, Moore PL.
    PLoS Pathog; 2017 Jan 06; 13(1):e1006074. PubMed ID: 28076415
    [Abstract] [Full Text] [Related]

  • 4. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.
    J Virol; 2016 Jan 13; 90(7):3446-57. PubMed ID: 26763999
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
    Zhang MY, Yuan T, Li J, Rosa Borges A, Watkins JD, Guenaga J, Yang Z, Wang Y, Wilson R, Li Y, Polonis VR, Pincus SH, Ruprecht RM, Dimitrov DS.
    PLoS One; 2012 Jan 13; 7(9):e44241. PubMed ID: 22970187
    [Abstract] [Full Text] [Related]

  • 6. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK, Pancera M, Phogat S, O'Dell S, McKee K, Guenaga J, Robinson J, Mascola J, Wyatt RT.
    AIDS Res Hum Retroviruses; 2011 Aug 13; 27(8):877-87. PubMed ID: 21158699
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.
    Lee JH, Leaman DP, Kim AS, Torrents de la Peña A, Sliepen K, Yasmeen A, Derking R, Ramos A, de Taeye SW, Ozorowski G, Klein F, Burton DR, Nussenzweig MC, Poignard P, Moore JP, Klasse PJ, Sanders RW, Zwick MB, Wilson IA, Ward AB.
    Nat Commun; 2015 Sep 25; 6():8167. PubMed ID: 26404402
    [Abstract] [Full Text] [Related]

  • 8. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, Mertens M, Herschhorn A, Melillo B, Smith AB, Sodroski J.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881646
    [Abstract] [Full Text] [Related]

  • 9. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
    Crooks ET, Tong T, Chakrabarti B, Narayan K, Georgiev IS, Menis S, Huang X, Kulp D, Osawa K, Muranaka J, Stewart-Jones G, Destefano J, O'Dell S, LaBranche C, Robinson JE, Montefiori DC, McKee K, Du SX, Doria-Rose N, Kwong PD, Mascola JR, Zhu P, Schief WR, Wyatt RT, Whalen RG, Binley JM.
    PLoS Pathog; 2015 May 01; 11(5):e1004932. PubMed ID: 26023780
    [Abstract] [Full Text] [Related]

  • 10. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
    Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, Finzi A, Kwon YD, Scheid JF, Shi W, Xu L, Yang Y, Zhu J, Nussenzweig MC, Sodroski J, Shapiro L, Nabel GJ, Mascola JR, Kwong PD.
    Science; 2010 Aug 13; 329(5993):811-7. PubMed ID: 20616231
    [Abstract] [Full Text] [Related]

  • 11. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
    Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, Schramm CA, Zhang Z, Zhu J, Shapiro L, NISC Comparative Sequencing Program, Mullikin JC, Gnanakaran S, Hraber P, Wiehe K, Kelsoe G, Yang G, Xia SM, Montefiori DC, Parks R, Lloyd KE, Scearce RM, Soderberg KA, Cohen M, Kamanga G, Louder MK, Tran LM, Chen Y, Cai F, Chen S, Moquin S, Du X, Joyce MG, Srivatsan S, Zhang B, Zheng A, Shaw GM, Hahn BH, Kepler TB, Korber BT, Kwong PD, Mascola JR, Haynes BF.
    Nature; 2013 Apr 25; 496(7446):469-76. PubMed ID: 23552890
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
    Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS.
    J Virol; 2004 Sep 25; 78(17):9233-42. PubMed ID: 15308718
    [Abstract] [Full Text] [Related]

  • 13. Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL.
    Kumar R, Pan R, Upadhyay C, Mayr L, Cohen S, Wang XH, Balasubramanian P, Nádas A, Seaman MS, Zolla-Pazner S, Gorny MK, Kong XP, Hioe CE.
    J Virol; 2015 Sep 25; 89(17):9090-102. PubMed ID: 26109728
    [Abstract] [Full Text] [Related]

  • 14. Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail.
    Durham ND, Yewdall AW, Chen P, Lee R, Zony C, Robinson JE, Chen BK.
    J Virol; 2012 Jul 25; 86(14):7484-95. PubMed ID: 22553332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.
    Evans MC, Phung P, Paquet AC, Parikh A, Petropoulos CJ, Wrin T, Haddad M.
    BMC Bioinformatics; 2014 Mar 19; 15():77. PubMed ID: 24646213
    [Abstract] [Full Text] [Related]

  • 17. HIV vaccine design and the neutralizing antibody problem.
    Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT.
    Nat Immunol; 2004 Mar 19; 5(3):233-6. PubMed ID: 14985706
    [No Abstract] [Full Text] [Related]

  • 18. Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
    Kumar S, Lin X, Ngo T, Shapero B, Sou C, Allen JD, Copps J, Zhang L, Ozorowski G, He L, Crispin M, Ward AB, Wilson IA, Zhu J.
    mBio; 2021 Jun 29; 12(3):e0042921. PubMed ID: 34156262
    [Abstract] [Full Text] [Related]

  • 19. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
    Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, O'Dell S, Perfetto S, Schmidt SD, Shi W, Wu L, Yang Y, Yang ZY, Yang Z, Zhang Z, Bonsignori M, Crump JA, Kapiga SH, Sam NE, Haynes BF, Simek M, Burton DR, Koff WC, Doria-Rose NA, Connors M, NISC Comparative Sequencing Program, Mullikin JC, Nabel GJ, Roederer M, Shapiro L, Kwong PD, Mascola JR.
    Science; 2011 Sep 16; 333(6049):1593-602. PubMed ID: 21835983
    [Abstract] [Full Text] [Related]

  • 20. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P, Gan J, Wu YQ, Zhang MY, Dimitrov DS, Ji X.
    J Mol Biol; 2006 Mar 17; 357(1):82-99. PubMed ID: 16426633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.